| pubmed-article:7800374 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7800374 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:7800374 | lifeskim:mentions | umls-concept:C0006849 | lld:lifeskim |
| pubmed-article:7800374 | lifeskim:mentions | umls-concept:C0024264 | lld:lifeskim |
| pubmed-article:7800374 | lifeskim:mentions | umls-concept:C0053396 | lld:lifeskim |
| pubmed-article:7800374 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:7800374 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:7800374 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:7800374 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:7800374 | lifeskim:mentions | umls-concept:C1515075 | lld:lifeskim |
| pubmed-article:7800374 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:7800374 | lifeskim:mentions | umls-concept:C0205191 | lld:lifeskim |
| pubmed-article:7800374 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:7800374 | pubmed:dateCreated | 1995-1-25 | lld:pubmed |
| pubmed-article:7800374 | pubmed:abstractText | Eleven HIV-positive patients with chronic oral candidiasis were supplemented with 60 to 120 mg of beta-carotene daily for 3 to 7 months. Lymphocyte profiles were evaluated at intervals to help assess immune competence. Although there was a modest increase in some lymphocyte values at 2 months, there was a significant decrease in numbers of CD4 and CD8 cells and CD4 percentage of lymphocytes after 6 months of beta-carotene supplementation. Serum triglyceride and liver enzyme levels were not affected by the beta-carotene supplementation. No improvement was observed in the control of the oral candidiasis. Under the conditions of the study, there was no indication that daily beta-carotene supplements enhanced immune competence or was of benefit in managing oral candidiasis. | lld:pubmed |
| pubmed-article:7800374 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7800374 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7800374 | pubmed:citationSubset | D | lld:pubmed |
| pubmed-article:7800374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7800374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7800374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7800374 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7800374 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:7800374 | pubmed:issn | 0030-4220 | lld:pubmed |
| pubmed-article:7800374 | pubmed:author | pubmed-author:StitesD PDP | lld:pubmed |
| pubmed-article:7800374 | pubmed:author | pubmed-author:ThompsonJ SJS | lld:pubmed |
| pubmed-article:7800374 | pubmed:author | pubmed-author:GalliPP | lld:pubmed |
| pubmed-article:7800374 | pubmed:author | pubmed-author:SilvermanSSJr | lld:pubmed |
| pubmed-article:7800374 | pubmed:author | pubmed-author:BrandtR BRB | lld:pubmed |
| pubmed-article:7800374 | pubmed:author | pubmed-author:KaugarsG EGE | lld:pubmed |
| pubmed-article:7800374 | pubmed:author | pubmed-author:RileyW TWT | lld:pubmed |
| pubmed-article:7800374 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7800374 | pubmed:volume | 78 | lld:pubmed |
| pubmed-article:7800374 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7800374 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7800374 | pubmed:pagination | 442-7 | lld:pubmed |
| pubmed-article:7800374 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:7800374 | pubmed:meshHeading | pubmed-meshheading:7800374-... | lld:pubmed |
| pubmed-article:7800374 | pubmed:meshHeading | pubmed-meshheading:7800374-... | lld:pubmed |
| pubmed-article:7800374 | pubmed:meshHeading | pubmed-meshheading:7800374-... | lld:pubmed |
| pubmed-article:7800374 | pubmed:meshHeading | pubmed-meshheading:7800374-... | lld:pubmed |
| pubmed-article:7800374 | pubmed:meshHeading | pubmed-meshheading:7800374-... | lld:pubmed |
| pubmed-article:7800374 | pubmed:meshHeading | pubmed-meshheading:7800374-... | lld:pubmed |
| pubmed-article:7800374 | pubmed:meshHeading | pubmed-meshheading:7800374-... | lld:pubmed |
| pubmed-article:7800374 | pubmed:meshHeading | pubmed-meshheading:7800374-... | lld:pubmed |
| pubmed-article:7800374 | pubmed:meshHeading | pubmed-meshheading:7800374-... | lld:pubmed |
| pubmed-article:7800374 | pubmed:meshHeading | pubmed-meshheading:7800374-... | lld:pubmed |
| pubmed-article:7800374 | pubmed:meshHeading | pubmed-meshheading:7800374-... | lld:pubmed |
| pubmed-article:7800374 | pubmed:meshHeading | pubmed-meshheading:7800374-... | lld:pubmed |
| pubmed-article:7800374 | pubmed:meshHeading | pubmed-meshheading:7800374-... | lld:pubmed |
| pubmed-article:7800374 | pubmed:meshHeading | pubmed-meshheading:7800374-... | lld:pubmed |
| pubmed-article:7800374 | pubmed:meshHeading | pubmed-meshheading:7800374-... | lld:pubmed |
| pubmed-article:7800374 | pubmed:meshHeading | pubmed-meshheading:7800374-... | lld:pubmed |
| pubmed-article:7800374 | pubmed:meshHeading | pubmed-meshheading:7800374-... | lld:pubmed |
| pubmed-article:7800374 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7800374 | pubmed:articleTitle | Clinical and lymphocyte responses to beta-carotene supplementation in 11 HIV-positive patients with chronic oral candidiasis. | lld:pubmed |
| pubmed-article:7800374 | pubmed:affiliation | Division of Oral Medicine, University of California at San Francisco School of Dentistry. | lld:pubmed |
| pubmed-article:7800374 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7800374 | pubmed:publicationType | Clinical Trial | lld:pubmed |
